Literature DB >> 20233828

Cancer's next frontier: addressing high and increasing costs.

Elena B Elkin1, Peter B Bach.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20233828      PMCID： PMC3647336          DOI： 10.1001/jama.2010.283

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

Review 1.  The burden of illness of cancer: economic cost and quality of life.

Authors:  M L Brown; J Lipscomb; C Snyder
Journal:  Annu Rev Public Health       Date:  2001       Impact factor: 21.981

2.  Benefit design and specialty drug use.

Authors:  Dana P Goldman; Geoffrey F Joyce; Grant Lawless; William H Crown; Vincent Willey
Journal:  Health Aff (Millwood)       Date:  2006 Sep-Oct       Impact factor: 6.301

3.  Does reimbursement influence chemotherapy treatment for cancer patients?

Authors:  Mireille Jacobson; A James O'Malley; Craig C Earle; Juliana Pakes; Peter Gaccione; Joseph P Newhouse
Journal:  Health Aff (Millwood)       Date:  2006 Mar-Apr       Impact factor: 6.301

4.  Limits on Medicare's ability to control rising spending on cancer drugs.

Authors:  Peter B Bach
Journal:  N Engl J Med       Date:  2009-01-27       Impact factor: 91.245

5.  Cancer therapy costs influence treatment: a national survey of oncologists.

Authors:  Peter J Neumann; Jennifer A Palmer; Eric Nadler; Chihui Fang; Peter Ubel
Journal:  Health Aff (Millwood)       Date:  2010 Jan-Feb       Impact factor: 6.301

6.  Building a bridge from fragmentation to accountability--the Prometheus Payment model.

Authors:  François de Brantes; Meredith B Rosenthal; Michael Painter
Journal:  N Engl J Med       Date:  2009-08-19       Impact factor: 91.245

7.  Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population.

Authors:  Christopher J Weight; Eric A Klein; J Stephen Jones
Journal:  Cancer       Date:  2008-05-15       Impact factor: 6.860

8.  Fostering accountable health care: moving forward in medicare.

Authors:  Elliott S Fisher; Mark B McClellan; John Bertko; Steven M Lieberman; Julie J Lee; Julie L Lewis; Jonathan S Skinner
Journal:  Health Aff (Millwood)       Date:  2009-01-27       Impact factor: 6.301

9.  Evaluation of trends in the cost of initial cancer treatment.

Authors:  Joan L Warren; K Robin Yabroff; Angela Meekins; Marie Topor; Elizabeth B Lamont; Martin L Brown
Journal:  J Natl Cancer Inst       Date:  2008-06-10       Impact factor: 13.506
  9 in total
  56 in total

1.  National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008.

Authors:  Didem S M Bernard; Stacy L Farr; Zhengyi Fang
Journal:  J Clin Oncol       Date:  2011-05-31       Impact factor: 44.544

2.  When to wait for more evidence? Real options analysis in proton therapy.

Authors:  Janneke P C Grutters; Keith R Abrams; Dirk de Ruysscher; Madelon Pijls-Johannesma; Hans J M Peters; Eric Beutner; Philippe Lambin; Manuela A Joore
Journal:  Oncologist       Date:  2011-12-06

3.  Should be NICE have a Spanish NICE?

Authors:  J Feliu; E Espinosa
Journal:  Clin Transl Oncol       Date:  2013-06-06       Impact factor: 3.405

4.  Advancing comparative studies of patterns of care and economic outcomes in cancer: challenges and opportunities.

Authors:  K Robin Yabroff; Silvia Francisci; Angela Mariotto; Maura Mezzetti; Anna Gigli; Joseph Lipscomb
Journal:  J Natl Cancer Inst Monogr       Date:  2013

5.  Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing.

Authors:  Nikhil G Thaker; Thomas J Pugh; Usama Mahmood; Seungtaek Choi; Tracy E Spinks; Neil E Martin; Terence T Sio; Rajat J Kudchadker; Robert S Kaplan; Deborah A Kuban; David A Swanson; Peter F Orio; Michael J Zelefsky; Brett W Cox; Louis Potters; Thomas A Buchholz; Thomas W Feeley; Steven J Frank
Journal:  Brachytherapy       Date:  2016-02-23       Impact factor: 2.362

6.  Financial burden experienced by patients undergoing treatment for malignant gliomas.

Authors:  Priya Kumthekar; Becky V Stell; Daniel I Jacobs; Irene B Helenowski; Alfred W Rademaker; Sean A Grimm; Charles L Bennett; Jeffrey J Raizer
Journal:  Neurooncol Pract       Date:  2014-05-05

7.  Implementation of cancer clinical care pathways: a successful model of collaboration between payers and providers.

Authors:  Bruce A Feinberg; James Lang; James Grzegorczyk; Donna Stark; Thomas Rybarczyk; Thomas Leyden; Joseph Cooper; Thomas Ruane; Scott Milligan; Philip Stella; Jeffrey A Scott
Journal:  J Oncol Pract       Date:  2012-05       Impact factor: 3.840

8.  Regional variation in spending and survival for older adults with advanced cancer.

Authors:  Gabriel A Brooks; Ling Li; Dhruv B Sharma; Jane C Weeks; Michael J Hassett; K Robin Yabroff; Deborah Schrag
Journal:  J Natl Cancer Inst       Date:  2013-03-12       Impact factor: 13.506

9.  Financial toxicity, Part I: a new name for a growing problem.

Authors:  S Yousuf Zafar; Amy P Abernethy
Journal:  Oncology (Williston Park)       Date:  2013-02       Impact factor: 2.990

10.  No stone unturned.

Authors:  Gregory A Petsko
Journal:  Genome Biol       Date:  2010-03-29       Impact factor: 13.583
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.